Dr. Freeman Describes Patient Navigation

Video

Dr. Harold P. Freeman from Ralph Lauren Center for Cancer Care and Prevention Describes Patient Navigation

Harold P. Freeman, MD, President and Founder of the Ralph Lauren Center for Cancer Care and Prevention in New York City, discusses patient navigation. Freeman is often considered the founder of the concept of patient navigation when he initiated the first patient navigation program in 1990 in Harlem to reduce racial disparities in access to the diagnosis and treatment of cancer.

Freeman describes patient navigation as a means to eliminating barriers and reducing the amount of time to diagnosis and treatment of cancer. Navigation begins before a patient is diagnosed with cancer by getting the patients to places where they can have access to appropriate screening. If any kind of abnormality is found, navigation is required to get those patients properly diagnosed. Once a diagnosis is made a patient must be navigated through the treatment process, which can often be very complex, depending on whether the patient is receiving surgery, radiation therapy, chemotherapy, or a combination. Navigation continues even after treatment through to survivorship.

Nurses can be utilized as navigators throughout the process, but Freeman said they play the most crucial role in the diagnosis of cancer.

Related Videos
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center